Related Experiment Videos
Experiences with a three step test scheme for embryotoxicity and teratogenicity.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|January 1, 1980
Summary
This study details a three-step teratological screening test to identify drug-induced birth defects. The test examines prenatal development, offspring viability, and fertility, aiding in the selection of safer medications.
Area of Science:
- Toxicology
- Developmental Biology
- Pharmacology
Background:
- Teratogenic side effects pose significant risks in drug development.
- Early identification of developmental toxicity is crucial for drug safety.
Purpose of the Study:
- To describe a comprehensive three-step teratological screening test.
- To evaluate the utility of this test in identifying teratogenic side effects.
Main Methods:
- Step I: Prenatal examination of fetuses for embryotoxicity, growth retardation, and teratogenicity.
- Step II: Peri- and postnatal examination of offspring, including viability, development, behavior, and potential transplacental tumor induction.
- Step III: Examination of offspring fertility and potential inclusion of a generation test.
Main Results:
- The described method provides a structured approach to assess developmental toxicity.
- Each step offers specific insights into potential adverse effects on offspring.
- The test aids in the selection of drugs with reduced teratogenic potential.
Conclusions:
- The three-step teratological screening test is a valuable tool for evaluating drug safety.
- This systematic approach enhances the identification of potential teratogenic side effects early in drug development.
- Implementing this screening strategy can improve the safety profile of new pharmaceutical agents.